Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v2-FR
Language French French
Date Updated 2017-11-06 2017-04-13
Drug Identification Number 02388669 02388669
Brand name LORAZEPAM INJECTION USP LORAZEPAM INJECTION USP
Common or Proper name LORAZEPAM LORAZEPAM
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 4MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 1mL Vial 10 x 1mL Vial
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-04-28 2017-04-28
Actual start date
Estimated end date 2017-10-31 2017-06-14
Actual end date 2017-10-30
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments